The estimated Net Worth of Lance A Berry is at least $8.31 millió dollars as of 10 February 2023. Mr. Berry owns over 95,238 units of Wright Medical NV stock worth over $4,043,912 and over the last 9 years he sold WMGI stock worth over $1,878,333. In addition, he makes $2,389,930 as Executive Vice President és Chief Financial and Operations Officer at Wright Medical NV.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Berry WMGI stock SEC Form 4 insiders trading
Lance has made over 20 trades of the Wright Medical NV stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 95,238 units of WMGI stock worth $100,000 on 10 February 2023.
The largest trade he's ever made was exercising 271,836 units of Wright Medical NV stock on 19 November 2019 worth over $5,811,854. On average, Lance trades about 12,692 units every 73 days since 2015. As of 10 February 2023 he still owns at least 134,887 units of Wright Medical NV stock.
You can see the complete history of Mr. Berry stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lance Berry biography
Lance A. Berry serves as Executive Vice President, Chief Financial and Operations Officer of the Company. He was appointed to that position in connection with the Wright/Tornier merger. Mr. Berry also serves as Senior Vice President and Chief Financial Officer of Wright Medical Group, Inc., a position he has held since 2009. He joined legacy Wright in 2002, and, until his appointment as Chief Financial Officer, served as Vice President and Corporate Controller. Prior to joining Wright, Mr. Berry served as audit manager with the Memphis, Tennessee office of Arthur Andersen LLP from 1995 to 2002.
What is the salary of Lance Berry?
As the Executive Vice President és Chief Financial and Operations Officer of Wright Medical NV, the total compensation of Lance Berry at Wright Medical NV is $2,389,930. There are 2 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
How old is Lance Berry?
Lance Berry is 47, he's been the Executive Vice President és Chief Financial and Operations Officer of Wright Medical NV since 2019. There are 20 older and 3 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
What's Lance Berry's mailing address?
Lance's mailing address filed with the SEC is 100 DOMAIN DRIVE, , EXETER, NH, 03833.
Insiders trading at Wright Medical NV
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman és Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
What does Wright Medical NV do?
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
What does Wright Medical NV's logo look like?
Complete history of Mr. Berry stock trades at Wright Medical NV és Vapotherm Inc
Wright Medical NV executives and stock owners
Wright Medical NV executives and other stock owners filed with the SEC include:
-
Robert Palmisano,
President and Chief Executive Officer, Executive Director -
Peter Cooke,
President, Emerging Markets, Australia and Japan -
Lance Berry,
Executive Vice President, Chief Financial and Operations Officer -
Kevin Cordell,
Executive Vice President, Chief Global Commercial Officer -
Andrew Morton,
Senior Vice President, Chief Human Resources Officer -
James Lightman,
Senior Vice President, General Counsel and Secretary -
Barry Regan,
Senior Vice President, Operations -
Jason Asper,
Senior Vice President, Chief Digital Officer -
David Stevens,
Non-Executive Independent Chairman of the Board -
Kevin O'Boyle,
Non-Executive Independent Director -
Elizabeth Weatherman,
Non-Executive Independent Director -
John Miclot,
Non-Executive Independent Director -
Richard Wallman,
Non-Executive Independent Director -
Gary Blackford,
Non-Executive Independent Director -
Amy Paul,
Non-Executive Independent Director -
James Mackin,
Non-Executive Independent Director -
Steven Wallace,
President, International -
Kevin Smith,
Senior Vice President, Quality and Regulatory -
Julie Dewey,
Senior Vice President, Chief Communications Officer -
Timothy Lanier,
President, Upper Extremities -
Patrick Fisher,
President, Lower Extremities -
Julie Andrews,
Senior Vice President, Global Finance -
Jennifer Walker,
Senior Vice President, Process Improvement -
J. Porter,
Senior Vice President, Chief Compliance Officer -
Tim Lanier,
President, Upper Extremities -
Sean Carney,
Director -
William L. Jr Griffin,
SVP GM BioMimetic Therapeutics -
Terry M. Rich,
President, Upper Extremities -
Gregory Morrison,
Sr. VP, Human Resources -
Robert P. Iii Burrows,
SVP, Supply Chain -
David H Mowry,
EVP and COO -
Ummersen Gordon Van,
Sr. VP, Product Delivery -
Holdings Cooperatief U.A.Wa...,
-
Alain Tornier,
Director -
Richard B Emmitt,
Director -
Kevin M Klemz,
Sr. VP, CLO and Secretary -
Shawn Mc Cormick,
Chief Financial Officer -
Medical Group N.V. Wright,
President, Lower Extremities